BiotechTube
Home/SonoVascular/Daniel Estay
DE

Daniel Estay

Founder & CEO

SonoVascular

Therapeutic Areas

CardiovascularVascular Diseases

SonoVascular Pipeline

DrugIndicationPhase
SonoThrombectomy™ SystemVenous Thromboembolism (VTE) / Deep Vein Thrombosis (DVT)Early Feasibility / First-in-Human

Leadership Team at SonoVascular

LH
Luke Harada
Chief Operating Officer
JR
Jacob Ruprecht
VP of Engineering
CN
Craig Nichols
VP of Clinical & RA/QA
BS
Bill Starling
Board Member
View full SonoVascular profile